Neuropilin-1, an immune checkpoint for controlling tumor-specific CD8 T-cell functions whose blockade improves anti-PD-1 immunotherapy

被引：0
|
作者：
Mami-Chouaib, Fathia [1 ,2 ]
机构：
[1] INSERM U1186, Villejuif, France
[2] Gustave Roussy, Villejuif, France
来源：
JOURNAL OF IMMUNOLOGY | 2020年 / 204卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
241.5
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
    Leclerc, Marine
    Voilin, Elodie
    Gros, Gwendoline
    Corgnac, Stephanie
    de Montpreville, Vincent
    Validire, Pierre
    Bismuth, Georges
    Mami-Chouaib, Fathia
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [2] Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
    Marine Leclerc
    Elodie Voilin
    Gwendoline Gros
    Stéphanie Corgnac
    Vincent de Montpréville
    Pierre Validire
    Georges Bismuth
    Fathia Mami-Chouaib
    Nature Communications, 10
  • [3] Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
    Krueger, Janna
    Santinon, Francois
    Kazanova, Alexandra
    Issa, Mark E.
    Larrivee, Bruno
    Kremer, Richard
    Milhalcioiu, Catalin
    Rudd, Christopher E.
    PLOS ONE, 2021, 16 (06):
  • [4] Blockade of IL-6 inhibits tumor immune evasion and improves anti-PD-1 immunotherapy
    Li, Wenyi
    Wu, Zhaokun
    Meng, Weidong
    Zhang, Chaoting
    Cheng, Mingzhen
    Chen, Yuehong
    Zou, Yini
    Li, Kejun
    Lin, Simin
    Xiong, Wenjun
    Wang, Ying
    Lin, Yixiong
    Ma, Wenhui
    Zhou, Weijie
    CYTOKINE, 2022, 158
  • [5] Neuropilin-1 Regulates the Secondary CD8 T Cell Response to Virus Infection
    Hwang, Ji Young
    Sun, Yanbo
    Carroll, Christopher R.
    Usherwood, Edward J.
    MSPHERE, 2019, 4 (03)
  • [6] CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy
    Ando, Satomi
    Araki, Koichi
    INTERNATIONAL IMMUNOLOGY, 2022, 34 (11) : 571 - 577
  • [7] Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1
    Sugiyarto, Gessa
    Lau, Doreen
    Hill, Samuel Luke
    Arcia-Anaya, David
    Boulanger, Denise S. M.
    Parkes, Eileen
    James, Edward
    Elliott, Tim
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [8] Tumor-specific CD8 T cell activation in draining lymph nodes supports the anti-tumor CD8 T cell response
    Prokhnevska, Nataliya
    Cardenas, Maria
    Jansen, Caroline
    Valanparambil, Rajesh
    Master, Viraj
    Sanda, Martin
    Kissick, Haydn
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [9] Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
    Tan, Shuguang
    Zhang, Catherine W-H
    Gao, George F.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2016, 1
  • [10] Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
    Shuguang Tan
    Catherine W-H Zhang
    George F Gao
    Signal Transduction and Targeted Therapy, 1
12345